Nedaplatin: a cisplatin derivative in cancer chemotherapy
about
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsA phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinomaNedaplatin enhanced apoptotic effects of ABT-737 in human cancer cells via Mcl-1 inhibition.Platinum-Based Adjuvant Chemotherapy for Stage II and Stage III Squamous Cell Carcinoma of the Lung.Future directions in esophageal cancer therapy.Pharmacokinetics and tissue distribution of novel platinum containing anticancer agent BP-C1 studied in rabbits using sector field inductively coupled plasma mass spectrometry.Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma.Novel therapies for advanced squamous cell carcinoma of the lung.Radiosensitization effect of nedaplatin on nasopharyngeal carcinoma cells in different status of Epstein-Barr virus infection.Clinical significance of a second-line chemotherapy regimen with paclitaxel, ifosfamide and nedaplatin for metastatic urothelial carcinoma after failure of cisplatin-based chemotherapy.Nedaplatin as a Single-Agent Chemotherapy May Support Palliative Therapy for Patients with Adenoid Cystic Carcinoma: A Case Report.Facile synthesis of highly biocompatible folic acid-functionalised SiO2 nanoparticles encapsulating rare-earth metal complexes, and their application in targeted drug delivery.Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non-small cell lung cancer.Bis(dimethylsulfoxide)carbonateplatinum(ii), a new synthon for a low-impact, versatile synthetic route to anticancer Pt carboxylates.Systemic treatment of advanced non-small cell lung cancer: controversies and perspectives.Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study
P2860
Q28066801-DE75C459-6BC2-4739-871B-174EBA06604CQ33435839-E60AC8A7-0F15-49FD-83FF-9A84F1C41836Q37407348-C5414DD1-F35A-4F44-B487-25AB4E11DC3EQ37695838-A6BE3B82-EBC4-4928-A4BD-49AB8C337611Q37747378-E173C1F2-C8C4-4CF0-87CA-654A91A605C8Q38275908-1396039B-DD4C-40E3-B63A-3FC7B43B087BQ38542060-84DBECDF-60AC-47C4-859F-EEFC93945146Q38734978-F14D90C1-BD4F-410F-A970-219CC0DA793FQ38988048-D0864810-526B-41B1-BEA9-8E732234D4CBQ40714083-CBB8316E-2C7A-45E7-B74F-F9BCB12039AFQ42365695-AC7CA17D-B46D-4ED7-9F6D-AB2D68F9B211Q47821565-C510A1FB-2631-44BC-9363-9E031B9EE322Q47903659-E421A670-AF61-4358-B045-4713D9ABEF41Q53781616-7CF8B8B4-CEAA-4B16-8606-A6D5F8B84687Q55417125-AF2F8BCA-1B5C-4D33-8BCF-4791F60074FCQ58696797-E2940FE6-477F-43A1-91D1-8F2A4E59AD4C
P2860
Nedaplatin: a cisplatin derivative in cancer chemotherapy
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Nedaplatin: a cisplatin derivative in cancer chemotherapy
@ast
Nedaplatin: a cisplatin derivative in cancer chemotherapy
@en
Nedaplatin: a cisplatin derivative in cancer chemotherapy
@nl
type
label
Nedaplatin: a cisplatin derivative in cancer chemotherapy
@ast
Nedaplatin: a cisplatin derivative in cancer chemotherapy
@en
Nedaplatin: a cisplatin derivative in cancer chemotherapy
@nl
prefLabel
Nedaplatin: a cisplatin derivative in cancer chemotherapy
@ast
Nedaplatin: a cisplatin derivative in cancer chemotherapy
@en
Nedaplatin: a cisplatin derivative in cancer chemotherapy
@nl
P2093
P2860
P3181
P356
P1476
Nedaplatin: a cisplatin derivative in cancer chemotherapy
@en
P2093
Hiroaki Itamochi
Junzo Kigawa
Muneaki Shimada
P2860
P3181
P356
10.2147/CMAR.S35785
P407
P577
2013-01-01T00:00:00Z